Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemal Mehta

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Expert Opinion on Biological Therapy|March 18, 2016
Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopiaKaivon Pakzad-Vaezi, Hemal Mehta, Zaid Mammo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosusDacheng Ding, Hemal Mehta, W Joseph McCune, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 30, 2016
Optical coherence tomography imaging of optic disc cavernous haemangiomaMohamed Katta, Hemal Mehta, Ivan Ho, et al.
Ophthalmology and Therapy|March 20, 2021
Presumed Sertraline-Associated Maculopathy: A Case SeriesHedayat Javidi, Sarah Ah-Moye, Charles Hennings, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|July 31, 2023
Novel Drug Delivery Methods and Approaches for the Treatment of Retinal DiseasesYeji Ham, Hemal Mehta, Jennifer Kang-Mieler, et al.
Retina (Philadelphia, Pa.)|July 9, 2016
METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONLeah N Kim, Hemal Mehta, Daniel Barthelmes, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|March 27, 2010
Transpositional Autokeratoplasty in a Patient with Unilateral Choroidal Melanoma and Contralateral Exposure KeratopathyHemal Mehta, John L Hungerford, David S Gartry, et al.
Ophthalmology. Retina|May 4, 2019
The Interval between Treatments of Bevacizumab and Dexamethasone Implants for Diabetic Macular Edema Increased over Time in the BEVORDEX TrialHemal Mehta, Samantha Fraser-Bell, Vuong Nguyen, et al.
The British Journal of Ophthalmology|August 6, 2017
Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedemaHemal Mehta, Samantha Fraser-Bell, Vuong Nguyen, et al.
The Cochrane Database of Systematic Reviews|April 19, 2018
Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedemaHemal Mehta, Charles Hennings, Mark C Gillies, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Expert Opinion on Biological Therapy|March 18, 2016
Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopiaKaivon Pakzad-Vaezi, Hemal Mehta, Zaid Mammo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosusDacheng Ding, Hemal Mehta, W Joseph McCune, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 30, 2016
Optical coherence tomography imaging of optic disc cavernous haemangiomaMohamed Katta, Hemal Mehta, Ivan Ho, et al.
Ophthalmology and Therapy|March 20, 2021
Presumed Sertraline-Associated Maculopathy: A Case SeriesHedayat Javidi, Sarah Ah-Moye, Charles Hennings, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|July 31, 2023
Novel Drug Delivery Methods and Approaches for the Treatment of Retinal DiseasesYeji Ham, Hemal Mehta, Jennifer Kang-Mieler, et al.
Retina (Philadelphia, Pa.)|July 9, 2016
METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONLeah N Kim, Hemal Mehta, Daniel Barthelmes, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|March 27, 2010
Transpositional Autokeratoplasty in a Patient with Unilateral Choroidal Melanoma and Contralateral Exposure KeratopathyHemal Mehta, John L Hungerford, David S Gartry, et al.
Ophthalmology. Retina|May 4, 2019
The Interval between Treatments of Bevacizumab and Dexamethasone Implants for Diabetic Macular Edema Increased over Time in the BEVORDEX TrialHemal Mehta, Samantha Fraser-Bell, Vuong Nguyen, et al.
The British Journal of Ophthalmology|August 6, 2017
Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedemaHemal Mehta, Samantha Fraser-Bell, Vuong Nguyen, et al.
The Cochrane Database of Systematic Reviews|April 19, 2018
Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedemaHemal Mehta, Charles Hennings, Mark C Gillies, et al.
Pageof 9